API Spatial Distribution Analysis: Chemical Mapping by Confocal Raman Microscopy
API spatial distribution analysis is point-by-point chemical mapping of where the active ingredient and excipients sit within a formulation. Using confocal Raman microscopy, Percevia generates chemical images that reveal homogeneity, segregation, agglomeration and component-rich domains, supporting dissolution investigation, batch comparison and process troubleshooting.
What is API spatial distribution analysis?
A conventional assay answers how much API is present in a sample. Spatial distribution answers a different question: where that API is located. Two samples with the same overall content can behave like distinct products, depending on whether the active is evenly dispersed or concentrated in specific domains.
Confocal Raman microscopy answers that question by collecting a grid of spectra point by point across the area of interest. Each spectrum is compared against reference signatures of the API, the excipients and available controls, and the dataset is converted into a chemical image that shows the relative location of each component, revealing API-rich domains, low-concentration regions and the contact between API and excipients.
Feasibility depends on the components' Raman response, matrix fluorescence, API concentration, domain size and sample preparation. Before promising a map, Percevia evaluates the analytical question, the matrix and the ability to distinguish the relevant signatures. Spatial resolution, sampling depth and spectral treatment are set in the analytical plan, and the report separates observation, processing and interpretation so the conclusion does not imply greater precision than the data support.
What spatial distribution reveals, and why it matters
Two samples with the same overall API content can behave like distinct products, depending on how that content is organized in space.
| What is observed | What it can indicate | Practical consequence |
|---|---|---|
| API-rich domains / agglomerates | Local active concentration well above the sample average, indicating agglomeration or incomplete mixing. | Can compromise content uniformity and dissolution, even when average content is within specification. |
| Low API-concentration regions | Areas where the active signal is absent or greatly reduced relative to the matrix. | Can indicate segregation during blending, granulation or compression, with a risk of localized under-dosing. |
| Uneven API–excipient contact | Interfaces with variable spatial overlap between components, visible only in the map, not in a bulk-content assay. | Can affect dissolution rate and, in specific cases, favor localized chemical interaction. |
| A spatial-organization difference between batches or products | A visibly distinct distribution pattern between a sample and a reference, even with comparable overall content. | Can signal an equivalence or performance risk that a conventional content assay would not capture. |
| Distribution consistency across the process | Comparison of maps across stages or batches of the same manufacturing process. | Helps isolate whether a performance failure originates in the formulation or in a specific process step. |
A chemical map shows relative distribution of components, not quantified content; quantification requires dedicated calibration and validation, and should not be inferred from map color intensity alone.
From spectrum to interpretable map
Method choice depends on the components' Raman response, the scale of the domain of interest and the analytical question. No technique enters the scope without answering a question the feasibility screening raised.
| Technique | What it measures | What decision it supports |
|---|---|---|
| Reference spectra | The vibrational signature specific to the API, the excipients and available controls. | Whether components can be distinguished under the study conditions, before any mapping. |
| Confocal Raman mapping | A grid of spectra collected point by point across the selected sample area. | The relative location of components and the degree of spatial heterogeneity. |
| Spectral processing and classification (chemometrics) | Correlation of each collected spectrum against the reference signatures, after baseline and noise correction. | Converts the raw spectral dataset into a traceable, comparable chemical map. |
| TERS · Tip-Enhanced Raman Spectroscopy | Chemical signature at nanometer scale, below the optical diffraction limit. | Whether domains too small to be resolved by conventional confocal Raman require higher-resolution confirmation. |
The analytical workflow
Every sample runs through the same logical sequence, with resolution, depth and processing strategy adjusted to the question and the matrix; not every sample is feasible for a high-resolution map.
Feasibility screening
Assessment of the matrix, known components, fluorescence and laser stability, and of the analytical question, to define whether and how mapping can answer it.
Feasibility opinion and study design
Reference spectra characterization
Collection of spectra from the API, the excipients and available controls, to confirm the relevant signatures can be distinguished under the real sample conditions.
A reference spectral library for the sample
Map acquisition and processing
Collection of the spectral grid across the defined area and resolution, followed by processing and classification to convert the raw data into a traceable chemical map.
Chemical maps and representative spectra per region
Interpretation and comparison
Comparison across regions, samples or batches included in scope, with an explicit discussion of the resolution, depth and identification limitations the method imposes.
An interpreted report, with limitations stated
Applications
The same chemical-imaging capability supports distinct investigations, from development through production troubleshooting.
Content uniformity
API homogeneity investigation
Checking how the active is distributed within a dosage unit, when a content-uniformity result raises a question about the cause.
Process troubleshooting
Segregation and agglomeration
Identifying API-rich or API-poor domains associated with a specific blending, granulation or compression step.
Batch comparison
Reference product, prototypes and batches
Comparing spatial organization between a reference product and a generic, prototype or development batch, beyond overall content.
Analytical complement
Support for deformulation and solid-state work
A spatial-imaging layer that complements solid-state characterization and deformulation, when the question is about location, not only identity or content.
What you receive
An interpreted technical report, not a set of loose colored maps.
Data and evidence
- Two-dimensional chemical maps applicable to the area and resolution of the study
- Representative spectra per component and per region of interest
- Reference spectra used to differentiate components
- A description of sample preparation, acquisition parameters and the spectral treatment applied
Interpretation and conclusions
- A description of the relative distribution observed and any atypical domains or regions
- Comparison across regions, samples or batches included in scope
- Discussion of spatial-resolution, sampling-depth and component-identification limitations
- Practical implications for content uniformity, dissolution or process investigation, where applicable
Scope and turnaround
Scope is set by the analytical question: a feasibility screening is enough for some samples, while a forensic comparison across batches requires a broader acquisition and processing design.
- Feasibility screening before any map is promised
- Spatial resolution, depth and processing strategy set in the analytical plan, not from a fixed parameter list
- Results expressed as relative distribution, not quantified content, unless a dedicated calibration design is scoped
- Comparison across regions, samples or batches as defined in scope
- Suited to homogeneity investigation, process troubleshooting and product comparison
Frequently asked questions
What is an API's spatial distribution?
- It is how the active pharmaceutical ingredient is located within a formulation, including whether it is evenly dispersed, agglomerated, or concentrated in specific regions. It is a different question from "how much" API is present, which is what a conventional content assay answers.
How does confocal Raman microscopy map an API's distribution?
- The instrument collects a Raman spectrum at each position of a defined grid across the sample. Each spectrum is compared against reference signatures of the API and excipients, and the result is converted into a spatial image showing where each component predominates.
Does Raman mapping measure quantitative API content?
- Not directly. A chemical map shows relative distribution of components. Quantification requires dedicated calibration, validation and experimental design, and should not be inferred from map color intensity alone.
Which samples can be evaluated?
- Solid formulations and other compatible matrices may be considered. Geometry, surface, fluorescence, laser stability and sample preparation must be assessed before method definition, which happens at the feasibility-screening stage.
Does spatial distribution replace a content-uniformity test?
- No. A content-uniformity test quantifies dose across units. Spatial mapping investigates the cause when that or another result raises the hypothesis of heterogeneity within a unit, complementing the information rather than replacing it.
What is the difference between spatial distribution and polymorphism?
- Spatial distribution answers where components are located. Polymorphism answers which crystalline form is present. The two questions can be answered on the same sample and often complement each other: confocal Raman can also differentiate polymorphic forms when they carry a distinct spectral signature.
What is TERS, and when is it needed?
- TERS (Tip-Enhanced Raman Spectroscopy) extends the technique's spatial resolution to the nanometer scale, below the optical diffraction limit of conventional confocal Raman. It is indicated when the domains of interest are too small to be resolved by standard confocal mapping.
Does confocal Raman mapping replace electron microscopy (SEM/SEM-EDX)?
- Not necessarily. Raman provides chemical information based on vibrational signature; SEM-EDX provides morphological and elemental information. The choice, or a combination of both, depends on what question the sample raises.
How long does a spatial distribution study take?
- It depends on the area mapped, the resolution needed and the number of samples compared, set after the feasibility screening. Turnaround is set in the proposal, after that initial stage.
Is the information submitted handled confidentially?
- Yes. Scope, samples, results and the existence of the study are treated as client confidential information, under a confidentiality agreement signed before samples are sent.
Services that complement spatial distribution analysis
Request a proposal
Scope is set by the analytical question: a feasibility screening is enough for some samples, while a forensic comparison across batches requires a broader acquisition and processing design.
Request a proposal